Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 25, 2021.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Alise Carlson, MD, a resident of Cleveland Clinic, details the factors and long-term effects that misdiagnoses can have on a patient with multiple sclerosis, particularly the impact on their quality of life.
The duo from Cleveland Clinic addressed several of their research projects presented at the American Headache Society 2021 Annual Scientific Meeting that covered a range of COVID-19 related topics, including the unknowns about associated headaches.
Joseph Sullivan, MD, and Elaine C. Wirrell, MD, key opinion leaders in the field of rare epilepsies, discuss the importance of early diagnosis of Dravet syndrome as well as seizure triggers and comorbidities.
Wendy Ziai, MD, MPH, notes that the moon shot opportunity to curing coma will take the efforts of everyone, and that collaboration is needed to move toward the grand challenge of awakening hope.
The clinical fellow at Massachusetts General Hospital discussed the basis of his recent study that evaluated adult neurology trainees and their familiarity with the occurrence of sudden unexpected death in epilepsy and its risks.
If you missed your chance to see the June broadcast of our free webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, don't fret! You can join Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, and others as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
To view the enduring version of either of the first 3 programs, click here for our Future Leaders in Neurology section.